NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

and so the FDA forced the screening halt to ensure no one new (except those in the pipeline for which vaccines were already made) entered the trial, why then would the FDA lift the screening halt in Feb 2017?

They lifted the hold when NWBO changed the trial to no longer plan on enrolling patients.

How could the FDA not accept NWBO's decision on to resolve the issue when NWBO did exactly when the FDA had been forcing? And when NWBO responded with the enrollment termination, the FDA had by law to either lift the hold or explain why the Spinsor's response did not address the FDA concern.